These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Ceramide promotes calpain-mediated proteolysis of protein kinase C beta in murine polymorphonuclear leukocytes.
    Author: Tanabe F, Cui SH, Ito M.
    Journal: Biochem Biophys Res Commun; 1998 Jan 06; 242(1):129-33. PubMed ID: 9439623.
    Abstract:
    Ceramide has been recognized as an important second messenger in intracellular signaling. We demonstrate here that ceramide promotes the down-regulation of protein kinase C (PKC) activity in phorbol ester-stimulated murine polymorphonuclear leukocytes (PMNs). As reported previously, treatment of PMNs with phorbol ester caused a translocation of PKC from the cytosolic to the membrane fractions. When PMNs were pretreated with cell-permeable ceramide analogue, C2-ceramide, the membrane-associated PKC activity was rapidly down-regulated by phorbol ester stimulation. E64-d, a potent inhibitor of calpain which proteolyzes PKC, eliminated the rapid down-regulation of PKC activity. By hydroxyapatite column chromatography and Western blotting, the predominant PKC isoform was PKC beta with a small amount of PKC alpha in murine PMNs. We found that ceramide strikingly promoted calpain-mediated proteolysis of PKC beta in vitro. Ceramide was also shown to inhibit [3H]phorbol 12,13-dibutyrate(PDBu) binding to PKC beta. Moreover, we show that ceramide stimulates PKC beta autophosphorylation. These results suggest that ceramide directly activates PKC beta and promotes calpain-mediated proteolysis in murine PMNs.
    [Abstract] [Full Text] [Related] [New Search]